Trial intelligence / Profile preview

Hemospan in Orthopedic Surgery

NCT00494949Phase 2Completed

Sponsor
Sangart
Start
Apr 2003
Primary completion
Jul 2006
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Hemospan in hypotension, hypoxia, sponsored by Sangart. Started Apr 2003; status: completed.

02

Drugs

Hemospan
03

Conditions

hypotensionhypoxia

Beyond the preview

Go deeper on NCT00494949.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00494949.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call